Italia markets closed
  • FTSE MIB

    22.848,58
    -214,97 (-0,93%)
     
  • Dow Jones

    30.932,37
    -469,64 (-1,50%)
     
  • Nasdaq

    13.192,35
    +72,92 (+0,56%)
     
  • Nikkei 225

    28.966,01
    -1.202,26 (-3,99%)
     
  • Petrolio

    61,66
    -1,87 (-2,94%)
     
  • BTC-EUR

    36.874,38
    -2.972,30 (-7,46%)
     
  • CMC Crypto 200

    912,88
    -20,25 (-2,17%)
     
  • Oro

    1.733,00
    -42,40 (-2,39%)
     
  • EUR/USD

    1,2088
    -0,0099 (-0,81%)
     
  • S&P 500

    3.811,15
    -18,19 (-0,48%)
     
  • HANG SENG

    28.980,21
    -1.093,96 (-3,64%)
     
  • Euro Stoxx 50

    3.636,44
    -48,84 (-1,33%)
     
  • EUR/GBP

    0,8667
    -0,0026 (-0,30%)
     
  • EUR/CHF

    1,0965
    -0,0048 (-0,43%)
     
  • EUR/CAD

    1,5380
    +0,0036 (+0,24%)
     

Charles River Laboratories International Inc (CRL) Corporate Executive VP & CFO David Ross ...

GuruFocus.com
·2 minuto per la lettura

- By insider

Corporate Executive VP & CFO of Charles River Laboratories International Inc (30-Year Financial, Insider Trades) David Ross Smith (insider trades) sold 8,656 shares of CRL on 02/19/2021 at an average price of $290.63 a share. The total sale was $2.5 million.


Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries. Charles River Laboratories International Inc has a market cap of $13.96 billion; its shares were traded at around $280.450000 with a P/E ratio of 38.95 and P/S ratio of 4.86. Charles River Laboratories International Inc had annual average EBITDA growth of 17.00% over the past five years. GuruFocus has detected 2 severe warning signs with Charles River Laboratories International Inc. .

CEO Recent Trades:

  • Chairman, President and CEO James C Foster sold 30,000 shares of CRL stock on 02/11/2021 at the average price of $285.02. The price of the stock has decreased by 1.6% since.

CFO Recent Trades:

  • Corporate Executive VP & CFO David Ross Smith sold 8,656 shares of CRL stock on 02/19/2021 at the average price of $290.63. The price of the stock has decreased by 3.5% since.

Directors and Officers Recent Trades:

  • Corporate Executive VP Birgit Girshick sold 1,675 shares of CRL stock on 02/19/2021 at the average price of $293.92. The price of the stock has decreased by 4.58% since.

  • CSVP&Chief Accounting Officer Michael Gunnar Knell sold 410 shares of CRL stock on 02/19/2021 at the average price of $290.99. The price of the stock has decreased by 3.62% since.

For the complete insider trading history of CRL, click here

.This article first appeared on GuruFocus.